George L. Sing, Director at REGENERON PHARMACEUTICALS INC (REGN), sold 15,000 shares at $340.00 ($5.1M) on 2014-02-21, disclosed to the SEC on 2014-02-24.
Open-market sale of $5.1M REGN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $338.00 | 5,000 | $1.7M | 33.2% |
| 2 | $339.00 | 5,000 | $1.7M | 33.3% |
| 3 | $340.00 | 5,000 | $1.7M | 33.4% |
| Total | $339.00 avg | 15,000 | $5.1M | 100% |
| Filing → |
| REGN | SELL | 2024-02-26 | $3.4M | — | Filing → |
| REGN | SELL | 2024-02-12 | $950K | — | Filing → |
| REGN | SELL | 2022-03-01 | $2.5M | — | Filing → |